AVANIR Pharmaceuticals Balance Sheet
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Assets | Sep 07 | Sep 06 | Sep 05 |
|---|---|---|---|
| Current Assets | |||
| Cash | 32.9 | 21.7 | 22.8 |
| Net Receivables | 1.0 | 3.0 | 1.2 |
| Inventories | 0.0 | 2.8 | 0.0 |
| Other Current Assets | 1.5 | 1.8 | 2.4 |
| Total Current Assets | 35.4 | 29.3 | 26.4 |
| Net Fixed Assets | 2.5 | 6.4 | 6.3 |
| Other Noncurrent Assets | 1.1 | 35.7 | 8.6 |
| Total Assets | 39.1 | 71.5 | 41.4 |
| Liabilities and Shareholder's Equity | Sep 07 | Sep 06 | Sep 05 |
| Current Liabilities | |||
| Accounts Payable | 3.5 | 22.6 | 12.1 |
| Short-Term Debt | 0.3 | 0.9 | 0.3 |
| Other Current Liabilities | 2.3 | 12.8 | 2.0 |
| Total Current Liabilities | 6.1 | 36.3 | 14.4 |
| Long-Term Debt | 11.8 | 24.9 | 0.6 |
| Other Noncurrent Liabilities | 14.2 | 15.9 | 17.2 |
| Total Liabilities | 32.1 | 77.1 | 32.3 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 7.0 | (5.7) | 9.1 |
| Total Equity | 7.0 | (5.7) | 9.1 |
| Shares Outstanding (mil.) | 43.1 | 31.7 | 0.0 |
This data is provided as per license from EDGAR Online
